Drug Detail

Information about Belzutifan

Generic Name	Belzutifan
IND	MK-6482
Brand Name (US)
Manufacturer
Drug Type
Delivery	Oral
Approval Status
Indications
Overall Strategy	Inhibit disrupted cell metabolism
Strategy	HIF-2a inhibitor
Drug Category	SDH-directed

Links
	Wikipedia

Trials of this drug
	Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

Trial results